NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Evaluate the Real-world Experience and Satisfaction Associated With Ofatumumab

CompletedN/A

Sponsor: Novartis Pharmaceuticals

Conditions: Multiple Sclerosis

Countries: Switzerland

The aim of this study was to assess physician and patient satisfaction with ofatumumab using data collected from physicians and their multiple sclerosis (MS) patients in real-world clinical practice across the United Kingdom (UK), France, Germany, Italy, Spain, China, Japan, and Brazil.

Eligibility overview

Sex: ALL

Age: 18 Years to 100 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Physician inclusion criteria:

* Physicians must be actively involved in the treatment/management of patients with MS
* Consult with a minimum of 16 MS patients (\>5 in Japan and China, \>10 in Brazil) per month

Patient inclusion criteria:

Patients for whom physicians complete a Physician Completed Patient Record Form (PRF), and therefore are included in the pool of data for analysis, are based on the following criteria:

* Patients who had a physician-made diagnosis of MS before or at the time of data collection
* Patients must not currently be involved in a clinical trial
* Patients ≥18 years old
* For patients included in the ofatumumab sample, they must have been receiving ofatumumab for \>12 months at the time of data collection

Exclusion criteria:

• None

Locations (1)

Basel, Switzerland